These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31693612)

  • 1. Gastric Mucosal Hypertrophy Masquerading as Metastasis From Neuroendocrine Tumor of the Pancreas Detected on 68Ga-DOTANOC PET/CT.
    Malik D; Elumalai R; Verma R; Belho ES; Seniaray N; Mahajan H
    Clin Nucl Med; 2020 Jan; 45(1):74-75. PubMed ID: 31693612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrapancreatic accessory spleen detected by 68Ga DOTANOC PET/CT and 99mTc-colloid SPECT/CT scintigraphy.
    Collarino A; del Ciello A; Perotti G; Rufini V
    Clin Nucl Med; 2015 May; 40(5):415-8. PubMed ID: 25275421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head-to-Head Comparison of 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT in Patients With Midgut Neuroendocrine Tumors.
    Ansquer C; Touchefeu Y; Faivre-Chauvet A; Leux C; Le Bras M; Régenet N; Fleury V; Maucherat B; Senellart H; Guyetant S; Carlier T; Scotet-Cérato E; Rauscher A; Frampas E; Kraeber-Bodéré F
    Clin Nucl Med; 2021 Mar; 46(3):181-186. PubMed ID: 33315677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined 18F-FDG PET/CT and 68Ga DOTATATE PET/CT "Superscan" in Metastatic Pancreatic Neuroendocrine Tumor.
    Chan M; Schembri GP
    Clin Nucl Med; 2017 Feb; 42(2):108-109. PubMed ID: 27997429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET/CT and 68Ga-DOTATOC PET/CT in Diffuse Pancreatic Neuroendocrine Tumor.
    Ji X; Dong A; He Q; Dong H; Zuo C
    Clin Nucl Med; 2020 May; 45(5):e245-e248. PubMed ID: 32049733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of Multiple Pancreatic Neuroendocrine Tumors Identified by 68Ga-DOTANOC and 68Ga-Exendin-4 PET/CT in a Patient with Endogenous Hyperinsulinemic Hypoglycemia and Multiple Endocrine Neoplasia 1.
    Xu J; Xu X; Zhang M; Liu W; Chen J; Song S
    Neuroendocrinology; 2024; 114(9):866-871. PubMed ID: 38471465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
    Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
    J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular Carcinoma Mimicking Neuroendocrine Tumor Metastasis on 68Ga-DOTATATE PET/CT.
    Ulaner GA; Bodei L
    Clin Nucl Med; 2019 Apr; 44(4):330-331. PubMed ID: 30688738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG DOTANOC Mismatch in In Vivo Characterization and Grading of Neuroendocrine Tumor.
    Mukherjee A; Agarwal KK; Bal C; Kumar R
    Clin Nucl Med; 2016 Dec; 41(12):e511-e513. PubMed ID: 27749422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare case of ectopic adrenocorticotropic hormone syndrome caused by a metastatic neuroendocrine tumor of the pancreas detected by 68Ga-DOTANOC and 18F-FDG PET/CT.
    Treglia G; Salomone E; Petrone G; Giaccari A; Rindi G; Rufini V
    Clin Nucl Med; 2013 Jul; 38(7):e306-8. PubMed ID: 23486330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Contrast-Enhanced CT + CT Enterography and 68Ga-DOTANOC PET/CT in Gastroenteropancreatic Neuroendocrine Tumors.
    Sharma A; Das CJ; Makharia GK; Arora G; Kumar R
    Clin Nucl Med; 2020 Nov; 45(11):848-853. PubMed ID: 32657875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and Therapeutic Uptake of Intrathyroid Metastasis of Midgut Neuroendocrine Tumor on 68Ga-DOTANOC PET/CT and 177Lu-DOTATATE Imaging.
    Vija Racaru L; Sinigaglia M; Fontaine S; DʼAure D; Courbon F; Dierickx L
    Clin Nucl Med; 2019 Jul; 44(7):e445-e448. PubMed ID: 31021912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-Body 68Ga-DOTANOC PET/MRI Versus 68Ga-DOTANOC PET/CT in Patients With Neuroendocrine Tumors: A Prospective Study in 28 Patients.
    Berzaczy D; Giraudo C; Haug AR; Raderer M; Senn D; Karanikas G; Weber M; Mayerhoefer ME
    Clin Nucl Med; 2017 Sep; 42(9):669-674. PubMed ID: 28682844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of Treatment Response to Trans-arterial Radio-embolization (TARE) on 68Ga-DOTANOC PET/CT in a Patient With Metastatic Neuroendocrine Tumor.
    Vadi SK; Mittal BR; Kumar R; Parihar AS; Shukla J; Kalra N
    Clin Nucl Med; 2018 Sep; 43(9):e312-e313. PubMed ID: 29939955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contemporary nuclear medicine diagnostics of neuroendocrine tumors].
    Srp Arh Celok Lek; 2015; 143(1-2):108-15. PubMed ID: 25845263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of Extramedullary Plasmacytomas Involving Lymph Nodes and Pancreas Revealed by 68Ga-DOTATATE and 18F-FDG PET/CT.
    Pan Q; Luo Y; Li J; Zhang S; Li F
    Clin Nucl Med; 2018 Dec; 43(12):936-938. PubMed ID: 30179917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin receptor expression in lymphomas: a source of false diagnosis of neuroendocrine tumor at
    Ruuska T; Ramírez Escalante Y; Vaittinen S; Gardberg M; Kiviniemi A; Marjamäki P; Kemppainen J; Jyrkkiö S; Minn H
    Acta Oncol; 2018 Feb; 57(2):283-289. PubMed ID: 28686510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
    Thapa P; Ranade R; Ostwal V; Shrikhande SV; Goel M; Basu S
    Nucl Med Commun; 2016 Oct; 37(10):1030-7. PubMed ID: 27243215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular imaging of late somatostatin receptor-positive metastases of renal cell carcinoma in the pancreas by 68Ga DOTATOC PET/CT: a rare differential diagnosis to multiple primary pancreatic neuroendocrine tumors.
    Peter L; Sänger J; Hommann M; Baum RP; Kaemmerer D
    Clin Nucl Med; 2014 Aug; 39(8):713-6. PubMed ID: 24561680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of (68)Ga-DOTATOC PET/CT in screening for pancreatic neuroendocrine tumour in patients with von Hippel-Lindau disease.
    Prasad V; Tiling N; Denecke T; Brenner W; Plöckinger U
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2014-20. PubMed ID: 27293206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.